-
公开(公告)号：WO2011058535A1
公开(公告)日：2011-05-19
申请号：PCT/IE2010/000066
申请日：2010-11-11
Applicant: ALIMENTARY HEALTH LIMITED , O'MAHONY, Liam , KIELY, Barry , CRYAN, John Francis , DINAN, Timothy , MURPHY, Eileen Frances
Inventor： O'MAHONY, Liam , KIELY, Barry , CRYAN, John Francis , DINAN, Timothy , MURPHY, Eileen Frances
CPC classification number: C12R1/01 , A23C9/1234 , A23G9/363 , A23L33/135 , A23V2002/00 , A23Y2300/55 , A61K35/745 , C12N1/20 , Y02A50/473 , A23V2200/3204 , A23V2200/324
Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
Abstract translation: 益生菌双歧杆菌菌株AH1714在口服消费后显着免疫调节。 该菌株可用作免疫调节生物治疗剂。
-
公开(公告)号：WO2005062879A9
公开(公告)日：2010-01-28
申请号：PCT/US2004043072
申请日：2004-12-17
Applicant: IAMS COMPANY , ALIMENTARY HEALTH LTD , BOILEAU THOMAS WILLIAM-MAXWELL , CEDDIA MICHAEL ANTHONY , COLLINS JOHN KEVIN , DAVENPORT GARY MITCHELL , KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , SUNVOLD GREGORY DEAN , TETRICK MARK ALAN , VICKERS ROBERT JASON
Inventor： BOILEAU THOMAS WILLIAM-MAXWELL , CEDDIA MICHAEL ANTHONY , COLLINS JOHN KEVIN , DAVENPORT GARY MITCHELL , KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , SUNVOLD GREGORY DEAN , TETRICK MARK ALAN , VICKERS ROBERT JASON
CPC classification number: C12N1/20 , A23K10/18 , A23K50/40 , A61K35/745 , C12R1/01
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
-
3.发明申请
公开(公告)号：WO2008053444A2
公开(公告)日：2008-05-08
申请号：PCT/IB2007054428
申请日：2007-10-31
Applicant: PROCTER & GAMBLE , ALIMENTARY HEALTH LTD , KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , LAWSON DAVID ALEXANDER
Inventor： KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , LAWSON DAVID ALEXANDER
CPC classification number: A61K35/745
Abstract: Disclosed herein are methods for treating a respiratory condition in a mammal, such as a human. The methods employ use of a composition comprising a Bifidobacterium probiotic.
Abstract translation: 本文公开了用于治疗哺乳动物（例如人）的呼吸状况的方法。 该方法使用包含双歧杆菌益生菌的组合物。
-
公开(公告)号：WO2005062878A2
公开(公告)日：2005-07-14
申请号：PCT/US2004/043071
申请日：2004-12-17
Applicant: THE IAMS COMPANY , ALIMENTARY HEALTH LTD , BOILEAU, Thomas, William-Maxwell , CEDDIA, Michael, Anthony , COLLINS, John, Kevin , DAVENPORT, Gary, Mitchell , KIELY, Barry, Pius , O'MAHONY, Liam, Diarmuid , SUNVOLD, Gregory, Dean , TETRICK, Mark, Alan , VICKERS, Robert, Jason
Inventor： BOILEAU, Thomas, William-Maxwell , CEDDIA, Michael, Anthony , COLLINS, John, Kevin , DAVENPORT, Gary, Mitchell , KIELY, Barry, Pius , O'MAHONY, Liam, Diarmuid , SUNVOLD, Gregory, Dean , TETRICK, Mark, Alan , VICKERS, Robert, Jason
CPC classification number: C12R1/01 , A23K10/16 , A23K10/18 , A23K50/40 , A23K50/42 , A23K50/45 , A23K50/48 , A23L33/135 , A61K35/745 , C12N1/20
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
Abstract translation: 根据本发明，提供了通过从动物中具有益生菌活性的切除和洗涤的犬胃肠道分离而获得的球孢双歧杆菌物种的乳酸菌菌株。 还提供了使用本发明的双歧杆菌双歧杆菌的使用方法和组合物。
-
公开(公告)号：WO2004087178A1
公开(公告)日：2004-10-14
申请号：PCT/IE2004/000050
申请日：2004-03-31
Applicant: ALIMENTARY HEALTH LIMITED , O'MAHONY, Liam , SHANAHAN, Fergus , KIELY, Barry , COLLINS, John, Kevin , O'SULLIVAN, Gerald, Christopher
Inventor： O'MAHONY, Liam , SHANAHAN, Fergus , KIELY, Barry , COLLINS, John, Kevin , O'SULLIVAN, Gerald, Christopher
IPC: A61K35/74
CPC classification number: A61K35/747 , A61K9/0019 , A61K39/07 , A61K47/02
Abstract: An injectable formulation of a bacterial strain such as a Lactobacillus salivarius strain is useful in treating of inflammatory disorders such as colitis or arthritis.
Abstract translation: 细菌菌株例如唾液乳杆菌菌株的可注射制剂可用于治疗炎症性疾病如结肠炎或关节炎。
-
Patent Agency Ranking
公开(公告)号：WO2005062878A3
公开(公告)日：2007-12-06
申请号：PCT/US2004043071
申请日：2004-12-17
Applicant: IAMS COMPANY , ALIMENTARY HEALTH LTD , BOILEAU THOMAS WILLIAM-MAXWELL , CEDDIA MICHAEL ANTHONY , COLLINS JOHN KEVIN , DAVENPORT GARY MITCHELL , KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , SUNVOLD GREGORY DEAN , TETRICK MARK ALAN , VICKERS ROBERT JASON
Inventor： BOILEAU THOMAS WILLIAM-MAXWELL , CEDDIA MICHAEL ANTHONY , COLLINS JOHN KEVIN , DAVENPORT GARY MITCHELL , KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , SUNVOLD GREGORY DEAN , TETRICK MARK ALAN , VICKERS ROBERT JASON
CPC classification number: C12R1/01 , A23K10/16 , A23K10/18 , A23K50/40 , A23K50/42 , A23K50/45 , A23K50/48 , A23L33/135 , A61K35/745 , C12N1/20
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
Abstract translation: 根据本发明，提供了通过从动物中具有益生菌活性的切除和洗涤的犬胃肠道分离而获得的球孢双歧杆菌物种的乳酸菌菌株。 还提供了使用本发明的双歧杆菌双歧杆菌的使用方法和组合物。
-
公开(公告)号：WO2005060709A2
公开(公告)日：2005-07-07
申请号：PCT/US2004/043070
申请日：2004-12-17
Applicant: THE IAMS COMPANY , ALIMENTARY HEALTH LTD , BOILEAU, Thomas, William-Maxwell , CEDDIA, Michael, Anthony , DAVENPORT, Gary, Mitchell , KIELY, Barry, Pius , O'MAHONY, Liam, Diarmuid , SUNVOLD, Gregory, Dean , TETRICK, Mark, Alan , VICKERS, Robert, Jason
Inventor： BOILEAU, Thomas, William-Maxwell , CEDDIA, Michael, Anthony , DAVENPORT, Gary, Mitchell , KIELY, Barry, Pius , O'MAHONY, Liam, Diarmuid , SUNVOLD, Gregory, Dean , TETRICK, Mark, Alan , VICKERS, Robert, Jason
CPC classification number: A61K35/745 , A23K10/18 , A23K50/40 , A23Y2300/00 , A61K2035/115 , C12N1/20 , Y10S435/822
Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Bifidobacteria .
Abstract translation: 根据本发明，提供了在伴侣动物中使用双歧杆菌属益生菌的方法。
-
公开(公告)号：WO2005060708A2
公开(公告)日：2005-07-07
申请号：PCT/US2004/043069
申请日：2004-12-17
Applicant: THE IAMS COMPANY , ALIMENTARY HEALTH LTD , BOILEAU, Thomas, William-Maxwell , CEDDIA, Michael, Anthony , COLLINS, John, Kevin , DAVENPORT, Gary, Mitchell , KIELY, Barry, Pius , O'MAHONY, Liam, Diarmuid , SUNVOLD, Gregory, Dean , TETRICK, Mark, Alan , VICKERS, Robert, Jason
Inventor： BOILEAU, Thomas, William-Maxwell , CEDDIA, Michael, Anthony , COLLINS, John, Kevin , DAVENPORT, Gary, Mitchell , KIELY, Barry, Pius , O'MAHONY, Liam, Diarmuid , SUNVOLD, Gregory, Dean , TETRICK, Mark, Alan , VICKERS, Robert, Jason
CPC classification number: C12N1/20 , A23K10/18 , A23K50/40 , A23L33/135 , A23Y2220/75 , A23Y2300/00 , A61K35/747 , C12R1/225 , Y10S426/805 , Y10S435/853
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
Abstract translation: 根据本发明，提供了一种乳酸杆菌属乳酸菌菌株，其可通过从动物中具有益生菌活性的切除和洗涤的犬胃肠道中分离获得。 还提供了包含本发明的乳杆菌的使用方法和组合物。
-
公开(公告)号：WO2003010299A1
公开(公告)日：2003-02-06
申请号：PCT/IE2002/000112
申请日：2002-07-26
Applicant: ALIMENTARY HEALTH LIMITED , COLLINS, John, Kevin , O'SULLIVAN, Gerald, Christopher , O'MAHONY, Liam , SHANAHAN, Fergus , KIELY, Barry
Inventor： COLLINS, John, Kevin , O'SULLIVAN, Gerald, Christopher , O'MAHONY, Liam , SHANAHAN, Fergus , KIELY, Barry
IPC: C12N1/20
CPC classification number: C12N1/20 , A23Y2220/17 , A61K35/747 , C12R1/245 , Y02A50/473
Abstract: A Lactobacillus casei strain or a mutant or variant thereof isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. In particular a Lactobacillus casei strain, AH101, AH104, AHlll, AHl12 or AHl13 or mutants or variants are thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
Abstract translation: 从切割和洗涤的人类胃肠道中分离的干酪乳杆菌菌株或突变体或变体在人类口服消耗后是显着的免疫调节。 特别地，干酪乳杆菌菌株AH101，AH104，AH11I，AH112或AH113或其突变体或变体可用于预防和/或治疗炎性活动，特别是不希望的胃肠炎症活动，例如炎性肠病或肠易激综合征。
-
公开(公告)号：WO2003010297A1
公开(公告)日：2003-02-06
申请号：PCT/IE2002/000110
申请日：2002-07-26
Applicant: ALIMENTARY HEALTH LIMITED , COLLINS, John, Kevin , O'SULLIVAN, Gerald, Christopher , O'MAHONY, Liam , SHANAHAN, Fergus , KIELY, Barry
Inventor： COLLINS, John, Kevin , O'SULLIVAN, Gerald, Christopher , O'MAHONY, Liam , SHANAHAN, Fergus , KIELY, Barry
IPC: C12N1/20
CPC classification number: C12N1/20 , A23L33/135 , A23Y2300/00 , A23Y2300/55 , A61K35/745 , C12R1/02
Abstract: A Bifidobacterium strain, AH208, AH209, AH2I0, AH2ll, AH212 or AH214 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.
Abstract translation: 双歧杆菌菌株，AH208，AH209，AH2I0，AH211，AH212或AH214或其突变体或变体可用于预防和/或治疗炎性活动，特别是不期望的胃肠炎症活动，例如炎性肠病 或肠易激综合征。
-
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.017 seconds)
